Q3 2025 agilon health inc Earnings Call Transcript
Key Points
- Agilon Health Inc (AGL) reported strong ACO REACH performance, with adjusted EBITDA ahead of expectations at $18 million.
- The company has reduced operating costs by $30 million, aiming for improved operating leverage and financial performance in 2026.
- Agilon Health Inc (AGL) has implemented an enhanced data pipeline, providing timely direct payer data feeds and member-level risk scores for 80% of its members.
- The company is actively negotiating improved contract economics for 2026, including reduced Part D exposure and enhanced quality incentives.
- Agilon Health Inc (AGL) achieved a consolidated average of 4.2 Stars across its markets for 2026 Star ratings, with 75% of members expected to be in 4-plus Star plans.
- Agilon Health Inc (AGL) reported a negative medical margin of $57 million and adjusted EBITDA of negative $91 million for the third quarter.
- The company faced lower-than-expected risk adjustment scores, impacting revenue by approximately $150 million for the full year.
- Membership declined year-over-year, with Medicare Advantage membership at 503,000 compared to 525,000 in Q3 2024.
- Agilon Health Inc (AGL) is experiencing continued high costs from exited markets, negatively impacting financial performance.
- The company is considering potential exits from payer contracts that do not meet profitability thresholds, which may reduce membership.
Good afternoon, and thank you all for attending the Agilon Health third-quarter 2025 earnings conference call. My name is Brika, and I will be your moderator for today. All lines will be muted during the presentation portion of the call, with an opportunity for questions and answers at the end.
I would now like to pass the conference over to your host, Evan Smith, Investor Relations at Agilon Health. Thank you. You may proceed, Evan.
Thank you, operator. Good afternoon, and welcome to the call. With me are Executive Chairman Ron Williams and our CFO, Jeff Schwaneke. Following our prepared remarks, we will conduct a Q&A session.
Before we begin, I would like to remind you that our remarks and responses to questions may include forward-looking statements. Actual results may differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with our business. These risks and uncertainties are discussed in our SEC filings.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
